Literature DB >> 20703505

The first clinical case in Japan of destination therapy using the Jarvik 2000 left ventricular assist device.

Sokichi Kamata1, Taichi Sakaguchi, Shigeru Miyagawa, Yasushi Yoshikawa, Takashi Yamauchi, Koji Takeda, Shunsuke Saito, Takayoshi Ueno, Toru Kuratani, Yoshiki Sawa.   

Abstract

A 73-year-old female with a history of surgical ventricular restoration for ischemic cardiomyopathy presented with biventricular heart failure symptoms. After a Toyobo paracorporeal left ventricular assist device (LVAD) was implanted as a bridge, she underwent successful implantation of a Jarvik 2000 LVAD. This device provided excellent symptomatic improvement. This is the first case in Japan of destination therapy using an implantable LVAD.

Entities:  

Mesh：

Year:  2010        PMID： 20703505     DOI： 10.1007/s10047-010-0512-1

Source DB:  PubMed          Journal:  J Artif Organs        ISSN： 1434-7229            Impact factor:   1.731


  6 in total

1.  Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist device.

Authors:  George V Letsou; Nyma Shah; Igor D Gregoric; Timothy J Myers; Reynolds Delgado; O H Frazier
Journal:  J Heart Lung Transplant       Date:  2005-01       Impact factor: 10.247

2.  Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failure.

Authors:  Ranjit John; Kenneth Liao; Katherine Lietz; Forum Kamdar; Monica Colvin-Adams; Andrew Boyle; Leslie Miller; Lyle Joyce
Journal:  J Thorac Cardiovasc Surg       Date:  2007-08       Impact factor: 5.209

3.  Destination therapy with a rotary blood pump and novel power delivery.

Authors:  Stephen Westaby; Michael Siegenthaler; Friedhelm Beyersdorf; Massimo Massetti; John Pepper; Andre Khayat; Roland Hetzer; Oscar Howard Frazier
Journal:  Eur J Cardiothorac Surg       Date:  2009-07-08       Impact factor: 4.191

4.  Use of quantitative analysis of remote myocardial fibrosis with delayed-enhancement magnetic resonance imaging to predict outcomes after surgical ventricular restoration for ischemic cardiomyopathy.

Authors:  Koji Takeda; Goro Matsumiya; Hajime Matsue; Seiki Hamada; Masayuki Sakaki; Taichi Sakaguchi; Tomoyuki Fujita; Yoshiki Sawa
Journal:  J Thorac Cardiovasc Surg       Date:  2008-05-19       Impact factor: 5.209

5.  Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.

Authors:  Katherine Lietz; James W Long; Abdallah G Kfoury; Mark S Slaughter; Marc A Silver; Carmelo A Milano; Joseph G Rogers; Yoshifumi Naka; Donna Mancini; Leslie W Miller
Journal:  Circulation       Date:  2007-07-16       Impact factor: 29.690

6.  Fifteen-year experience with Toyobo paracorporeal left ventricular assist system.

Authors:  Shunsuke Saito; Goro Matsumiya; Taichi Sakaguchi; Tomoyuki Fujita; Toru Kuratani; Hajime Ichikawa; Yoshiki Sawa
Journal:  J Artif Organs       Date:  2009-03-29       Impact factor: 1.731
  6 in total
  2 in total

Review 1.  Journal of Artificial Organs 2010: the year in review.

Authors: 
Journal:  J Artif Organs       Date:  2011-03-16       Impact factor: 1.731

2.  Clinical results with Jarvik 2000 axial flow left ventricular assist device: Osaka University Experience.

Authors:  Daisuke Yoshioka; Goro Matsumiya; Koichi Toda; Taichi Sakaguchi; Yasushi Yoshikawa; Shunsuke Saito; Hikaru Matsuda; Yoshiki Sawa
Journal:  J Artif Organs       Date:  2014-07-22       Impact factor: 1.731
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.